Background of Roche Company in Switzerland

As the largest biotechnology company in the world, Roche provides innovative products and services from early detection, prevention, diagnosis and treatment, making outstanding contributions in many fields and improving human health and quality of life. Roche is a global leader in in vitro diagnosis, anti-tumor drugs and transplantation drugs; Is a market leader in virology. It is also active in other key diseases such as autoimmune diseases, inflammation, metabolism and central nervous system diseases. In 2007, the sales of pharmaceutical sector reached 36.8 billion Swiss francs, and the sales of diagnostic sector reached 9.3 billion Swiss francs. In 2007, Roche invested more than 8 billion Swiss francs in R&D and established R&D business alliances with many partners, including Genentech and Chinese and foreign pharmaceutical companies controlled by Roche. Roche Group * * * has about 80,000 employees.

Roche is committed to continuous innovation to provide patients with more and more effective new drugs. Many excellent products owned by the pharmaceutical sector have become milestones in the field of drug therapy, and it is for this reason that it has established its leading position in the global pharmaceutical market. Looking forward to the future, Roche's professional skills in medical chemistry and biotechnology make it have great potential in new drug research and development, and it is more based on the ranks of global leaders.

Roche Diagnostics has a wide range of business, providing diversified and innovative testing products and services for researchers, doctors, patients, hospitals and laboratories all over the world. More than 23,000 employees around the world are dedicated to scientific research, product research and development, product market operation, services and integrated solutions, with branches in more than 40 countries. We will devote ourselves to providing excellent service, improving customers' work efficiency and creating higher value for customers, employees, shareholders and society.